Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Alopecia areata does not affect areas with psoriasis plaques.

Cryotherapy may be an effective and simple treatment for mild hair loss with few side effects.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Cyclosporin doesn't stop hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

An imbalanced gut and lack of biotin can cause hair loss in mice.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Both mouse and rat models are effective for testing alopecia areata treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.